Frank Amato, previously Chief Operating Officer, has been appointed Chief Executive Officer of electroCore LLC. This change is part of a management-proposed development plan, unanimously approved by the company's Board, designed to position the company for its next phase of growth. Mr. Amato, who joined electroCore in 2012 as COO, has extensive commercial experience in the pharmaceutical industry, most recently holding the position of US Vice President, Specialty Commercial Operations Group, at Merck.

Founder and Board Member, JP Errico, who previously held the role of Chief Executive Officer, is transitioning to Chief Science and Strategy Officer, and will focus on leading the team that will spearhead the development of nVNS into other therapeutic areas in the CNS and beyond.